Form 8-K for CORGENIX MEDICAL CORP/CO
28-Feb-2008
Change in Directors or Principal Officers, Financial Statements and Exhi
ITEM 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
Dr. Charles H. Scoggin resigned from the Board of Directors of Corgenix Medical Corporation, effective February 26, 2008. Dr. Scoggin, who became a director in March 2006, indicated to Douglass Simpson, the Company's President and CEO, that he was resigning due to the demands of his other business ventures.
The vacancy left by Dr. Scoggin's departure has been filled with the appointment of Mr. Stephen P. Gouze. From 1998 through 2007, Mr. Gouze was President of DiaSorin, Inc., the U.S. subsidiary of a $250 million international Diagostic Company, DiaSorin, S.p.A., a company focusing on hepatitis, endocrinology and instrumentation. In that capacity, he had complete profit and loss responsibility for the subsidiary. From 1997 to 1998, Mr. Gouze was Vice President, Sales and Marketing of IncSTAR Corporation, the predecessor company of DiaSorin. From 1994 to 1997, Mr. Gouze was Vice President, Sales and Marketing for PathCor, Inc. (Medical Arts Laboratory), an Oklahoma City clinical testing laboratory. From 1989 to 1994, Mr. Gouze was the Director of Marketing of Sanofi Diagnostics Pastueur, a major international diagnostic company focusing on blood viruses, autoimmunity and allergies, and from 1987 to 1989, he was the Marketing Manager of Kellestad Diagnostics, Inc. (now part of BioRad Laboratories, Inc.), a predecessor division of Sanofi Diagostics Pastueur. Mr. Gouze received a Bachelor of Science Degree in Medical Technology from the University of Wisconsin. |
